The Oregonian cites OHSU forecast, noting that hospitalizations statewide could rise to around 315 in June, well below the 1,130 people in the hospital during the peak of the omicron surge, with about half of those being incidental cases.

Oregon Public Broadcasting reports that cases are up but severity is down.

In 2016, he volunteered at Oregon Health and Science University where he assists researchers, physicians and faculty in assessing the commercial potential for technologies.

Emergency responders in portions of Clackamas, Washington and Yamhill counties are participating in a new nationwide clinical trial through OHSU testing two strategies to help patients who require breathing assistance at the scene of a trauma.

The Oregonian publishes a letter to the editor regarding an email phishing test in April for which OHSU apologized.

Co-author Babak Nazer, M.D., says: “As a male electrophysiologist in a predominantly male field, I have had the privilege of working closely with several remarkable female colleagues in our field. … We hope that these findings, and future topics we plan to investigate, elucidate the barriers to growing female representation in our field, which I feel will benefit both our patients and ourselves."

Atul Deodhar, M.D., is quoted about the FDA approving a new oral medication to treat ankylosing spondylitis, a form of spinal arthritis.

Almost half of older adults experience low back pain. Roger Chou, M.D., says medication “should be an adjunct for older adults, and not the main treatment. It’s important to be cautious, and try to use the lowest dose possible, for the shortest period of time”

MedPage Today reports on results from a new strategy to reduce opioid prescriptions following lateral neck dissection for thyroid cancer at OHSU. Jennifer March, M.D., says: “While we should be striving to reduce the prescription of the drugs, we have to realize that every patient case is unique and we have to consider the patient at the heart of the matter. Overall, we should be paying more attention to the amount of opioids being prescribed.”

In a story about state and federal efforts to increase use of and access to the COVID-19 antiviral pill Paxlovid, Michael Deam, R.Ph., says demand for the pill has increased significantly at OHSU Health pharmacies during the past week.